tiprankstipranks
Shivalik Rasayan Ltd (IN:SHIVALIK)
:SHIVALIK
India Market
Want to see IN:SHIVALIK full AI Analyst Report?

Shivalik Rasayan Ltd (SHIVALIK) AI Stock Analysis

0 Followers

Top Page

IN:SHIVALIK

Shivalik Rasayan Ltd

(SHIVALIK)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 5.2)
Rating:56Neutral
Price Target:
₹265.00
▼(-26.13% Downside)
Action:Reiterated
Date:05/28/26
The score is driven primarily by weaker fundamental quality due to sustained negative operating/free cash flow and reduced profitability, partially offset by a low-leverage balance sheet and steady revenue growth. Technicals are also a headwind given negative momentum and a longer-term downtrend, while valuation is only mildly supportive with a moderate P/E and minimal dividend yield.
Positive Factors
Revenue Growth
Multi-year top-line growth demonstrates durable demand for the company’s chemical and API products. Sustained revenue increases provide a base to absorb cyclical volatility, support scale benefits, and enable reinvestment in capacity or quality initiatives that underpin long-term competitiveness.
Negative Factors
Negative Operating Cash Flow
Sustained negative operating cash flow points to cash conversion and working-capital stress rather than one-off timing. Over months this erodes liquidity, forces dependence on cash reserves or financing, and limits the firm’s ability to fund day-to-day operations, invest in growth, or respond to supply-chain shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Multi-year top-line growth demonstrates durable demand for the company’s chemical and API products. Sustained revenue increases provide a base to absorb cyclical volatility, support scale benefits, and enable reinvestment in capacity or quality initiatives that underpin long-term competitiveness.
Read all positive factors

Shivalik Rasayan Ltd (SHIVALIK) vs. iShares MSCI India ETF (INDA)

Shivalik Rasayan Ltd Business Overview & Revenue Model

Company Description
Shivalik Rasayan Ltd. engages in the manufacture of pharmaceutical and agrochemical products. Its products include organophosphorous based insecticides and chemicals. The company was founded by Rahul Bishnoi on March 16, 1979 and is headquartered ...
How the Company Makes Money
The company primarily makes money by manufacturing and selling chemical products (including APIs, intermediates, and other specialty/fine chemicals) to customers, generating revenue from product sales. Its earnings are driven by volumes sold and r...

Shivalik Rasayan Ltd Financial Statement Overview

Summary
Steady revenue growth and a conservatively levered balance sheet support fundamentals, but profitability has weakened versus 2022–2023 and cash generation is a major concern with negative operating cash flow (2023–2026) and persistently negative free cash flow.
Income Statement
66
Positive
Balance Sheet
78
Positive
Cash Flow
22
Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue3.38B3.68B3.12B2.73B2.34B2.07B
Gross Profit1.30B1.00B805.70M1.33B1.20B533.21M
EBITDA503.80M457.65M485.11M461.64M493.13M534.26M
Net Income140.50M121.36M166.96M127.17M212.35M256.06M
Balance Sheet
Total Assets8.04B8.19B7.34B6.92B5.78B4.88B
Cash, Cash Equivalents and Short-Term Investments468.39M343.68M279.69M377.38M306.71M707.58M
Total Debt1.00B1.14B938.83M859.67M655.12M411.22M
Total Liabilities2.18B2.20B1.98B1.85B1.59B1.24B
Stockholders Equity5.87B5.99B5.36B3.90B3.10B2.87B
Cash Flow
Free Cash Flow-267.77M-581.61M-294.37M-757.31M-821.81M-138.32M
Operating Cash Flow-168.43M-414.68M-86.05M-80.75M-189.49M111.34M
Investing Cash Flow-157.64M-233.18M-208.31M-743.08M-707.72M-233.56M
Financing Cash Flow514.76M711.84M196.69M894.49M496.34M782.07M

Shivalik Rasayan Ltd Technical Analysis

Technical Analysis Sentiment
Negative
Last Price358.75
Price Trends
50DMA
258.10
Negative
100DMA
284.37
Negative
200DMA
363.73
Negative
Market Momentum
MACD
-1.87
Positive
RSI
47.19
Neutral
STOCH
62.62
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SHIVALIK, the sentiment is Negative. The current price of 358.75 is above the 20-day moving average (MA) of 262.32, above the 50-day MA of 258.10, and below the 200-day MA of 363.73, indicating a bearish trend. The MACD of -1.87 indicates Positive momentum. The RSI at 47.19 is Neutral, neither overbought nor oversold. The STOCH value of 62.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:SHIVALIK.

Shivalik Rasayan Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
₹9.20B19.3215.32%158.73%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
61
Neutral
₹4.65B25.420.82%3.24%6.11%
61
Neutral
₹4.96B20.0727.49%151.36%
59
Neutral
₹2.68B17.691.49%1.73%-35.32%
56
Neutral
₹4.06B34.680.13%18.04%-30.39%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:SHIVALIK
Shivalik Rasayan Ltd
257.75
-330.74
-56.20%
IN:BODALCHEM
Bodal Chemicals Limited
73.03
-1.54
-2.07%
IN:DICIND
DIC India Limited
506.10
-141.30
-21.83%
IN:MANORG
Mangalam Organics Ltd
579.55
8.65
1.52%
IN:PODDARMENT
Poddar Pigments Limited
252.90
-47.89
-15.92%
IN:SRD
Shankar Lal Rampal Dye-Chem Ltd.
40.99
-18.59
-31.20%

Shivalik Rasayan Ltd Corporate Events

Shivalik Rasayan Publishes Audited Results for Quarter and Year Ended March 31, 2026
May 28, 2026
Shivalik Rasayan Limited announced that its Board of Directors has approved the audited financial results for the quarter and full year ended March 31, 2026, at a meeting held on May 27, 2026. The company has also published these audited financial...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 28, 2026